| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 297.09▼ | 296.31▼ | 296.83▼ | 295.58▲ | 302.50▼ |
| MA10 | 296.83▼ | 297.49▼ | 297.75▼ | 299.55▼ | 304.31▼ |
| MA20 | 296.48▼ | 297.85▼ | 297.02▼ | 302.91▼ | 314.21▼ |
| MA50 | 297.36▼ | 295.84▲ | 297.83▼ | 305.28▼ | 359.79▼ |
| MA100 | 297.84▼ | 298.21▼ | 300.93▼ | 323.01▼ | 360.58▼ |
| MA200 | 296.87▼ | 301.55▼ | 301.37▼ | 356.97▼ | 391.25▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.109▲ | -0.358▼ | -0.038▼ | -0.636▼ | 0.378▲ |
| RSI | 43.448▼ | 45.194▼ | 47.051▼ | 45.169▼ | 37.720▼ |
| STOCH | 76.774 | 18.217▼ | 40.525 | 29.149 | 37.096 |
| WILL %R | -84.507▼ | -80.680▼ | -80.680▼ | -76.101▼ | -78.718▼ |
| CCI | -53.742 | -54.786 | -88.443 | -60.062 | -105.943▼ |
|
Wednesday, August 14, 2019 09:33 AM
Regeneron Pharmaceuticals (NASDAQ:REGN) announces the successful outcome of a Phase 3 clinical trial, ELIPSE HoFH, evaluating evinacumab in patients with an inherited form of severely elevated ...
|
|
Wednesday, August 14, 2019 06:33 AM
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has received ample support from multiple catalysts this week. On Tuesday, the company announced FDA approval for its prefilled Eylea syringe. The good news ...
|
|
Wednesday, August 14, 2019 04:17 AM
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive pivotal Phase 3 results for evinacumab, an investigational angiopoietin-like 3 (ANGPTL3) antibody, in patients with homozygous ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/08/19 | 295.32 | 300.9958 | 294.99 | 296.03 | 558,780 |
| 19/08/19 | 299.34 | 300.82 | 296.80 | 298.38 | 781,200 |
| 16/08/19 | 295.32 | 297.35 | 290.72 | 296.85 | 730,200 |
| 15/08/19 | 295.37 | 296.91 | 290.47 | 293.11 | 564,000 |
| 14/08/19 | 301.83 | 304.30 | 292.42 | 293.53 | 676,400 |
| 13/08/19 | 298.13 | 306.86 | 296.94 | 304.86 | 519,974 |
| 12/08/19 | 298.64 | 305.10 | 295.61 | 295.87 | 542,400 |
| 09/08/19 | 308.84 | 310.18 | 299.98 | 304.89 | 519,800 |
| 08/08/19 | 305.11 | 310.10 | 303.895 | 309.63 | 674,366 |
| 07/08/19 | 297.07 | 304.44 | 294.39 | 302.33 | 797,395 |
|
|
||||
|
|
||||
|
|